Showing results (1-10 of 468) with videos related to

Sort By:
Pageof 47
Current Opinion in Hematology|September 22, 2015
Donor-derived CD19-targeted T cells in allogeneic transplantsChiara Francesca Magnani, Andrea Biondi, Ettore Biagi
Immunology Letters|October 1, 2013
Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectorsSarah Tettamanti, Chiara Francesca Magnani, Andrea Biondi, et al.
Oncoimmunology|August 2, 2014
CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?Sarah Tettamanti, Andrea Biondi, Ettore Biagi, et al.
Journal of Autoimmunity|August 28, 2017
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemiaAndrea Biondi, Chiara F Magnani, Sarah Tettamanti, et al.
Current Pharmaceutical Design|June 26, 2012
From bone marrow transplantation to cellular therapies: possible therapeutic strategies in managing autoimmune disordersAndrea Taddio, Andrea Biondi, Elisa Piscianz, et al.
Frontiers in Oncology|May 4, 2013
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectivesChiara F Magnani, Sarah Tettamanti, Francesca Maltese, et al.
Experimental Hematology|August 31, 2006
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapyVirna Marin, Erica Dander, Ettore Biagi, et al.
Transfusion|June 3, 2008
Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation devicePaolo Perseghin, Giovanna D'Amico, Erica Dander, et al.
Haematologica|March 7, 2007
Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignanciesEttore Biagi, Virna Marin, Greta Maria Paola Giordano Attianese, et al.
Human Gene Therapy Methods|November 29, 2012
Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cellsVirna Marin, Elisabetta Cribioli, Brian Philip, et al.
Pageof 47